UK Companies House feature
ELANCO UK AH LIMITED
Profile
- Company number
- 11378434
- Status
- Active
- Incorporation
- 2018-05-23
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have assessed the ability of Elanco Animal Health Incorporated to provide the level of support that might be required and see no reason to believe that a material uncertainty exists that may cast significant doubt about the ability of Elanco UK AH Limited to continue as a going concern. On the basis of their assessment of the company's financial position, the Company's Directors have a reasonable expectation that the company will be able to continue in operational existence for the foreseeable future.”
Subsidiaries
- Dista Products Limited · 100% held · UK · Ordinary share Capital
- Elanco Europe Limited · 100% held · UK · Ordinary share Capital
- Vericore Limited · 100% held · UK · Ordinary share Capital
- Elanco Animal Health UK Limited · 100% held · UK · Ordinary share Capital
- Elanco Animal Vaccines Limited · 100% held · UK · Ordinary share Capital
Significant events
- “In July 2024, Elancó globally completed the sale of its Aqua portfolio to Merck for $1.3bn, the proceeds of which contributed to debt paydown. For Elanco UK, Aqua was a relatively small business unit and has resulted in a reduction in annualised revenues of approximately £6.5m.”
- “In November 2024, the Company acquired a manufacturing facility in Speke, Liverpool which was owned and operated by a third party contract manufacturer until its administration in the 2nd half of 2024... result[ing] in our decision to acquire this manufacturing facility, safeguarding product supply and the employment of approximately 260 people...”
- “Under the UK Emissions Trading Scheme Order, the Company's Speke facility... had a failure to acquire and surrender credits... resulting in an outstanding liability to the Environment Agency (EA)... The legal basis for such a transfer is highly uncertain. The Company is cooperating with the EA... to demonstrate that it should not be held liable for costs incurred before the acquisition date.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DAVIS, Nicholas | Director | 2025-04-01 | Jun 1975 | British |
| FROST, Matthew Jonathan | Director | 2021-07-01 | Jul 1972 | British |
| LEWIS, Christopher | Director | 2018-06-20 | Aug 1978 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AMBANI, Nilesh (Neel) Sukumar | Director | 2018-05-23 | 2018-12-07 |
| HUNT, Kristina Mary | Director | 2018-12-07 | 2026-01-23 |
| TROUTT, Peter | Director | 2018-06-20 | 2021-12-03 |
| VANHERSECKE, Francois Jean-Noel Emile | Director | 2019-09-05 | 2021-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Elanco Europe Gmbh | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, significant-influence-or-control-as-firm | 2019-03-11 | Ceased 2019-03-11 |
| Elanco Animal Health Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-03-11 | Active |
| Eli Lilly And Company Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-05-23 | Ceased 2019-03-11 |
Filing timeline
Last 20 of 43 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-29 | TM01 | officers | termination director company with name termination date |
| 2025-11-07 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-08-21 | AA | accounts | accounts with accounts type full |
| 2025-06-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-22 | AP01 | officers | appoint person director company with name date |
| 2024-09-18 | MR05 | mortgage | mortgage charge part release with charge number |
| 2024-09-10 | AA | accounts | accounts with accounts type full |
| 2024-07-23 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-06-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-09 | AA | accounts | accounts with accounts type full |
| 2023-09-20 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2023-09-20 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2023-06-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-10-07 | AA | accounts | accounts with accounts type full |
| 2022-07-06 | RESOLUTIONS | resolution | resolution |
| 2022-07-06 | MA | incorporation | memorandum articles |
| 2022-06-16 | CH01 | officers | change person director company with change date |
| 2022-05-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-01-05 | AA | accounts | accounts with accounts type full |
| 2021-12-03 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.